Analyzing Circulating Tumor Cells One at a Time
- PMID: 29891227
- PMCID: PMC6153072
- DOI: 10.1016/j.tcb.2018.05.004
Analyzing Circulating Tumor Cells One at a Time
Abstract
Whole-genome sequencing has made a significant impact on cancer research, but traditional bulk methods fail to detect information from rare cells. Recently developed single-cell sequencing methods have provided new insights and unprecedented details about cancer progression and diversity. These advancements also enable the investigation of rare cells, such as circulating tumor cells (CTCs) derived from cancer patients. In this review, we outline various single-cell sequencing techniques that can elucidate the molecular properties of CTCs. In addition, we explain the drawbacks that need to be overcome for each method.
Keywords: Circulating tumor cells; single-cell sequencing; tumor heterogeneity.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Single circulating tumor cell sequencing as an advanced tool in cancer management.Expert Rev Mol Diagn. 2016;16(1):51-63. doi: 10.1586/14737159.2016.1116942. Epub 2015 Nov 26. Expert Rev Mol Diagn. 2016. PMID: 26560087 Review.
-
Molecular characterization of circulating tumor cells-from bench to bedside.Semin Cell Dev Biol. 2018 Mar;75:88-97. doi: 10.1016/j.semcdb.2017.09.013. Epub 2017 Sep 9. Semin Cell Dev Biol. 2018. PMID: 28899718 Review.
-
Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.Expert Rev Mol Diagn. 2016;16(1):25-38. doi: 10.1586/14737159.2016.1121099. Epub 2015 Dec 5. Expert Rev Mol Diagn. 2016. PMID: 26567956 Review.
-
Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).Cancer Genomics Proteomics. 2017 May-Jun;14(3):173-179. doi: 10.21873/cgp.20029. Cancer Genomics Proteomics. 2017. PMID: 28446532 Free PMC article.
-
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.Oncotarget. 2016 May 3;7(18):26107-19. doi: 10.18632/oncotarget.8431. Oncotarget. 2016. PMID: 27034166 Free PMC article.
Cited by
-
Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases.APMIS. 2019 May;127(5):386-424. doi: 10.1111/apm.12934. APMIS. 2019. PMID: 31124204 Free PMC article. Review.
-
A Review of Circulating Tumour Cell Enrichment Technologies.Cancers (Basel). 2021 Feb 26;13(5):970. doi: 10.3390/cancers13050970. Cancers (Basel). 2021. PMID: 33652649 Free PMC article. Review.
-
Biomarkers in Cancer Detection, Diagnosis, and Prognosis.Sensors (Basel). 2023 Dec 20;24(1):37. doi: 10.3390/s24010037. Sensors (Basel). 2023. PMID: 38202898 Free PMC article. Review.
-
Circulating Tumor Cells and Breast Cancer Metastasis: From Enumeration to Somatic Mutational Profile.J Clin Med. 2022 Oct 14;11(20):6067. doi: 10.3390/jcm11206067. J Clin Med. 2022. PMID: 36294386 Free PMC article.
-
Circulating tumor cells in colorectal cancer in the era of precision medicine.J Mol Med (Berl). 2022 Feb;100(2):197-213. doi: 10.1007/s00109-021-02162-3. Epub 2021 Nov 20. J Mol Med (Berl). 2022. PMID: 34802071 Free PMC article. Review.
References
-
- Alix-Panabieres C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem. 2013;59(1):110–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources